PBM roundup: the top 6 actions to watch
It is already shaping up to be a tough year for Pharmacy Benefit Managers (PBMs) as federal regulators and politicians work to shed light …
It is already shaping up to be a tough year for Pharmacy Benefit Managers (PBMs) as federal regulators and politicians work to shed light …
If you are a regular reader of Bio.News, you likely know that the past two years have been difficult for the biotech market. Investor …
As biotech market seeks rebound, economic and political environments are key Read More »
“Biotech in space” may sound like the title of an old sci-fi movie but the real-life partnership offers tantalizing potential, an I am BIO …
I am BIO Podcast: Space station launches low-gravity biotech advances Read More »
After weeks of tension, the Supreme Court decided mifepristone can stay… for now. On the evening of April 21, the Supreme Court ruled the …
Supreme Court says mifepristone can stay – for now Read More »
With an upsurge in sexually transmitted infections (STIs) as well as the threat of antimicrobial resistance (AMR), the U.S. must take essential action to …
U.S. surge in STIs threatens to converge with antimicrobial resistance Read More »
The American Association for Cancer Research (AACR) hosted its 114th annual meeting in Florida in April. Scientists, medical professionals, and many others came together …
5 new discoveries at the American Association for Cancer Research annual meeting Read More »
Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR). …
We’re losing the fight against superbugs. The time to act is now. Read More »
With the Texas ruling against the product mifepristone on April 7, the biotech industry came together to both denounce the ruling and help the …
The week in mifepristone and understanding the deeper impacts Read More »
Concerns over sepsis, a life-threatening reaction to infections, are on the rise. And growing antimicrobial resistance (AMR) is making the condition harder to treat. …
Why pediatric sepsis is on the rise – and what we can do about it Read More »
On April 18, the House Energy and Commerce Innovation, Data, and Commerce Subcommittee held a hearing on the Federal Trade Commission’s (FTC) budget for …
House Energy & Commerce subcommittee spotlights ‘unfair’ PBM practices Read More »